Prediction of BRCA1 and BRCA2 mutation status using post-irradiation assays of lymphoblastoid cell lines is compromised by inter-cell-line phenotypic variability.

doi:10.1007/s10549-006-9415-5

Article

Prediction of BRCA1 and BRCA2 mutation status using post-irradiation assays of lymphoblastoid cell lines is compromised by inter-cell-line phenotypic variability.

Breast cancer research and treatment - 1 Sept 2007

Lovelock Paul K, Wong Ee Ming, Sprung Carl N, Marsh Anna, Hobson Karen, French Juliet D, Southey Melissa, Sculley Tom, Pandeya Nirmala, Brown Melissa A, Chenevix-Trench Georgia, Spurdle Amanda B, McKay Michael J

Abstract excerpt

BACKGROUND AND PURPOSE: Assays to determine the pathogenicity of unclassified sequence variants in disease-associated genes include the analysis of lymphoblastoid cell lines (LCLs). We assessed the ability of several assays of LCLs to distinguish carriers of germline BRCA1 and BRCA2 gene mutations from mutation-negative controls to determine their utility for use in a diagnostic setting. MATERIALS AND METHODS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Prediction of BRCA1 and BRCA2 mutation status using post-irradiation assays of lymphoblastoid cell lines is compromised by inter-cell-line phenotypic variability.

Abstract excerpt

Topics

Related research